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Abstract: The visualization of the level and pattern of apnea and hypopnea events is of pivotal
importance in the diagnosis and therapeutic decision-making for sleep-disordered breathing (SDB).
There are numerous techniques available to assess upper airway obstruction, which include imaging,
acoustic analysis, pressure transducer recording, and endoscopic evaluation. Drug-induced sleep
endoscopy (DISE) is a diagnostic tool that allows the dynamic, three-dimensional evaluation of
the patterns of vibration and collapse of the upper airway of SDB patients. DISE may change the
initial surgical planning in a high percentage of cases. A universally accepted and methodologically
standardized DISE could provide significant insight into its role to improve surgical outcomes.
However, up to now the ideal DISE protocol remains an open question.
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1. Introduction
The diagnostic assessment of the upper airway (UA) in sleep-disordered breathing (SDB), especially
for snoring and obstructive sleep apnea (OSA) patients, has undergone tremendous evolution over time.
This includes the introduction of several assessment techniques in the awake setting and procedures
that can observe the UA vibratory dynamics and/or collapse patterns during sleep.
In 1978, Borowiecki et al. [1] were the first to propose endoscopic evaluation of OSA patients under
natural sleep condition. However, this technique was limited to an experimental setting because of the
discomfort caused to patients and the long duration needed to assess each patient. Likewise, dynamic
imaging techniques (real-time magnetic resonance, computed tomography, etc.) may represent a precise
method to study the entire UA simultaneously, but imaging techniques are also very time-consuming
and are limited by the high cost for each study. Dynamic UA imaging can be challenging in daily
practice as it requires close collaboration between different departments. Furthermore, maneuvers or
body positioning during sleep imaging can be almost impossible.
In the last two decades, drug-induced sleep endoscopy (DISE) has gained importance in daily
practice because it can take a snapshot of the dynamic, three-dimensional UA during pharmacologically
induced sleep, within a short time [2–4].
In this chapter, we review the literature on the use of DISE in treatment decision-making and
analyze the impact of DISE on treatment outcomes.
Healthcare 2019, 7, 100; doi:10.3390/healthcare7030100 www.mdpi.com/journal/healthcare
Healthcare 2019, 7, 100 2 of 5
2. DISE Usefulness in Treatment Decision-Making Processes
Recent therapeutic protocols for OSA patients increasingly involve a combined/multimodal
surgical and non-surgical therapy, replacing the previous focus on one main treatment option, the so
called "one size fits all" approach [5–7].
Continuous positive airway pressure (CPAP) remains the first line treatment for patients with
moderate to severe OSA. However, CPAP therapy is associated with decreasing compliance over time
with reported failure rates ranging from 40 to 85% [8–10].
The surgical treatment options for OSA are usually determined by the patient characteristics
(UA anatomy, OSA severity, body mass index, and medical comorbidities), surgeon’s experience and
preference, and technological equipment availability (e.g., surgical robot, coblator, radiofrequency
devices, barbed suture, etc.). In addition, the literature has reported many different types of
non-standardized surgical procedures for both palatal and hypopharyngeal levels, performed using a
wide variety of techniques with different technological devices [11].
Positional therapy is an effective treatment option for patients with significant positional OSA
(POSA) [12]. Furthermore, a mandibular advancement device (MAD) can play an important role in the
treatment of selected mild to moderate grades of OSA [13]. Finally, the emerging literature supports
the positive effects of myofunctional therapy [14] in OSA patients.
DISE is a first-line UA diagnostic procedure that can help guide treatment option selection for
OSA patients.
DISE allows the visualization of the sites and patterns of partial or total UA collapse under
different levels of sedation. This may be useful in the selection of surgical candidates amongst the
OSA patients.
Considering the huge variety of surgical options including some non-standard procedures, it
is of pivotal importance to diagnose OSA with a sleep study and assess the three-dimensional UA
anatomical obstruction using DISE.
The UA anatomy can change significantly from the awake to the sleep state, mainly due to the
decrease in UA musculature tone. Only DISE can visualize the dynamic UA three-dimensional change
when the patient is under sedation [15].
According to some authors, DISE may provide useful data to help select the most efficient surgical
technique, reduce the rate of unnecessary multilevel (and thus more extensive) surgical resection, and
potentially improve surgical success rates [16].
Vanderveken et al. demonstrated the importance of DISE in predicting the success rate of
implanted hypoglossal nerve stimulation. The absence of total circumferential palatal collapse during
DISE is associated with better therapeutic success [17].
In a retrospective study by Soares et al., it was found that any significant lateral oropharyngeal wall
collapse and/or supraglottic collapse during DISE may be associated with worse surgical outcome [18].
More recently, a multicenter cohort study by Green et al. reported that any DISE findings of lateral
oropharyngeal wall obstruction and complete tongue obstruction pattern may lead to a higher risk of
surgical failure [19].
Positional therapy is an effective treatment option for patients with POSA. POSA is defined when
the apnea–hypopnea index (AHI) is at least 5 with a supine AHI that is at least 2 times higher than the
non-supine AHI [20]. Sleep position must be recorded in a sleep study for the diagnosis of POSA. A
sleep study may still miss the diagnosis of POSA if the patient only sleeps in a pure supine or pure
non-supine position [21]. Even when the diagnosis of POSA is not made, DISE performed in different
sleep positions may still identify potential candidates that may benefit from positional therapy. POSA
patients (who may or may not be previously diagnosed) should demonstrate at least partial widening
of the upper airway in a non-supine position [21].
Head rotation alone, with the body in supine position, during DISE may be adequate to predict
the positive effect of position change on the upper airway size of POSA patients [22], even if the latest
literature data highlighted the importance of lateral head and trunk rotation on UA patency during
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drug-induced sleep endoscopy in POSA patients [23]. Patients with significant improvement in UA
patency in a non-supine position will likely benefit from positional therapy.
MAD is a good treatment choice for suitable patients with mild to moderate OSA. To simulate MAD,
manual jaw advancement by about 5 mm can be performed during DISE [24]. If good improvement in
UA size can be demonstrated with manual jaw advancement during DISE, the patient will likely benefit
from MAD therapy [23]. The application of a custom-made simulation-bite in pre-adjusted maximum
comfortable protrusion during DISE may further improve the accuracy of the MAD’s effect [25].
Myofunctional therapy has become a new effective therapy for both pediatric and adult OSA.
It can be a stand-alone treatment or used in combination with both surgical and/or non-surgical
treatment [14]. DISE can be performed before and after myofunctional therapy to assess improvement
in the tongue muscular motion during sleep after a duration of therapy.
3. Role of DISE in Predicting Treatment Outcomes
Certal et al. published a recent systematic review comparing UA awake examination versus
DISE as diagnostic tools for surgical decision-making. A total of eight studies with 535 patients were
included in the review. Surgical treatment was changed after DISE in 50.24% cases. The change in
surgical planning was mainly due to the presence of hypopharyngeal or laryngeal dynamic collapse
that is only seen on DISE. However, the change in surgical planning did not lead to a significantly
higher success rate [26].
Very few studies analyzed the actual implications of DISE on surgical success, and the results
of these studies appear heterogeneous. Overall, no solid consensus could be reached by analyzing
the literature.
Blumen et al. showed that even when all the obstructed sites on DISE were treated surgically, it
did not always lead to treatment success. The additional sites detected by DISE may actually lead to
unnecessary procedures. Oversedation, prolonged DISE assessment, oversensitive observation, and
misunderstanding of the DISE findings (e.g., missing the primary cause of secondary obstruction sites)
may lead to additional artificially obstructed sites [27].
In a recent nonrandomized, prospective, multicenter clinical trial, Pang et al. studied 356 OSA
patients from nine tertiary clinical centers in seven different countries, including Singapore, Canada,
India, Spain, Poland, Israel, and Korea. The authors reported better surgical outcomes for OSA
patients with no preoperative DISE (no-DISE group) compared to patients who had undergone DISE.
Nevertheless, the authors remarked that the no-DISE group had more nasal surgery performed
(p < 0.001) which might have led to better outcomes in this group. Furthermore, despite reporting the
use of the European Position Paper on DISE protocol, the detailed DISE techniques from different
centers were not homogeneous. For example, every center has its own preferred sedative agents, such
as intravenous propofol or dexmedetomidine. Finally, remarkably variable surgical techniques were
performed by each of the surgeons from the different centers [28].
Eichler et al. also reported significant changes to the final treatment decision from awake to DISE
analysis for both surgical options (63.9% of patients) and the MAD patients’ group (78.4%) [29].
Aktas et al. found that the surgical treatment of DISE obstruction sites led to increased treatment
success. Their detailed analysis revealed a higher surgical success rate for patients with superior UA
obstruction. On the other hand, surgery for inferior UA collapse was associated with a poorer success
rate [30].
The addition of real-time cardio-respiratory monitoring during DISE may further improve the
correlation between respiratory events and UA collapse [31]. Video recording of DISE may also be
useful to study the upper airway patterns in OSA patients.
In conclusion, there is no general consensus on the role of DISE in predicting surgical
success [26], even though DISE provides useful information regarding specific UA patterns of
collapse (circumferential vs. anteroposterior soft palate pattern of collapse, predominant pharyngeal
lateral wall collapse, etc.) that are associated with potential surgical failure.
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4. Conclusions
The aim of UA assessment in OSA patients is to give a clear insight into the complex
pathophysiology of UA collapse and to improve treatment success rates. UA assessment in OSA
patients are often limited by the static findings in the awake setting, which usually do not represent the
dynamic UA collapse during sleep. DISE provides an alternative method of UA assessment using a
fiberoptic endoscope during pharmacologically induced sedation.
It is challenging to systematically review the literature on DISE due to the heterogeneous
DISE protocols and highly variable treatment options. So far, the literature has demonstrated that
preoperative DISE tends to change the initial surgical planning, but the improvement in surgical
outcomes remains an open question. Nevertheless, DISE provides useful UA evaluation, which enables
the identification of UA patterns of collapse associated with potential surgical failure.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Borowiecki, B.; Pollak, C.P.; Weitzman, E.D.; Rakoff, S.; Imperato, J. Fibro-optic study of pharyngeal airway
during sleep in patients with hypersomnia obstructive sleep-apnea syndrome. Laryngoscope 1978, 88,
1310–1313. [CrossRef] [PubMed]
2. Croft, C.B.; Pringle, M. Sleep nasendoscopy: A technique of assessment in snoring and obstructive sleep
apnoea. Clin. Otolaryngol. Allied Sci. 1991, 16, 504–509. [CrossRef] [PubMed]
3. De Vito, A.; Llatas, M.C.; Vanni, A.; Bosi, M.; Braghiroli, A.; Campanini, A.; de Vries, N.; Hamans, E.;
Hohenhorst, W.; Kotecha, B.T.; et al. European position paper on drug-induced sedation endoscopy (DISE).
Sleep Breath. 2014, 18, 453–465. [CrossRef] [PubMed]
4. De Vito, A.; Carrasco Llatas, M.; Ravesloot, M.J.; Kotecha, B.; De Vries, N.; Hamans, E.; Maurer, J.; Bosi, M.;
Blumen, M.; Heiser, C.; et al. European position paper on drug-induced sleep endoscopy: 2017 Update.
Clin. Otolaryngol. 2018, 43, 1541–1552. [CrossRef] [PubMed]
5. Riley, R.W.; Powell, N.B.; Guilleminault, C. Obstructive sleep apnea syndrome: A review of 306 consecutively
treated surgical patients. Otolaryngol. Head Neck Surg. 1993, 108, 117–125. [CrossRef]
6. Sethukumar, P.; Kotecha, B. Tailoring surgical interventions to treat obstructive sleep apnoea: One size does
not fit all. Breathe 2018, 14, e84–e93. [CrossRef]
7. Deacon, N.L.; Jen, R.; Li, Y.; Malhotra, A. Treatment of Obstructive Sleep Apnea. Prospects for Personalized
Combined Modality Therapy. Ann. Am. Thorac. Soc. 2016, 13, 101–108. [CrossRef]
8. Virk, J.S.; Kotecha, B. Otorhinolaryngological aspects of sleep-related breathing disorders. J. Thorac. Dis.
2016, 8, 213–223.
9. Donovan, L.M.; Boeder, S.; Malhotra, A.; Patel, S.R. New developments in the use of positive airway pressure
for obstructive sleep apnea. J. Thorac. Dis. 2015, 7, 1323–1342.
10. Virk, J.S.; Kotecha, B. When continuous positive airway pressure (CPAP) fails. J. Thorac. Dis. 2016, 8,
E1112–E1121. [CrossRef]
11. Chong, K.B.; De Vito, A.; Vicini, C. Drug-Induced Sleep Endoscopy in Treatment Options Selection.
Sleep Med. Clin. 2019, 14, 33–40. [CrossRef] [PubMed]
12. Beyers, J.; Vanderveken, O.M.; Kastoer, C.; Boudewyns, A.; De Volder, I.; Van Gastel, A.; Verbraecken, J.A.;
de Backer, W.A.; Braem, M.J.; van de Heyning, P.H.; et al. Treatment of sleep-disordered breathing with
positional therapy: Long-term results. Sleep Breath. 2019, 18, 1–9. [CrossRef] [PubMed]
13. Cammaroto, G.; Galletti, C.; Galletti, F.; Galletti, B.; Galletti, C.; Gay-Escoda, C. Mandibular advancement
devices vs nasal-continuous positive airway pressure in the treatment of obstructive sleep apnoea. Systematic
review and meta-analysis. Med. Oral Patol. Oral Cir. Bucal 2017, 22, e417–e424. [CrossRef] [PubMed]
14. Camacho, M.; Certal, V.; Abdullatif, J.; Zaghi, S.; Ruoff, C.M.; Capasso, R.; Kushida, C.A. Myofunctional
Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Sleep 2015, 38, 669–675.
[CrossRef] [PubMed]
Healthcare 2019, 7, 100 5 of 5
15. Lechner, M.; Wilkins, D.; Kotecha, B. A review on drug-induced sedation endoscopy—Technique, grading
systems and controversies. Sleep Med. Rev. 2018, 41, 141–148. [CrossRef] [PubMed]
16. Huntley, C.; Chou, D.; Doghramji, K.; Boon, M. Preoperative Drug Induced Sleep Endoscopy Improves the
Surgical Approach to Treatment of Obstructive Sleep Apnea. Ann. Otol. Rhinol. Laryngol. 2017, 126, 478–482.
[CrossRef] [PubMed]
17. Vanderveken, O.M.; Maurer, J.T.; Hohenhorst, W.; Hamans, E.; Lin, H.S.; Vroegop, A.V.; Anders, C.;
de Vries, N.; Van de Heyning, P.H. Evaluation of drug-induced sleep endoscopy as a patient selection tool
for implanted upper airway stimulation for obstructive sleep apnea. J. Clin. Sleep Med. 2013, 9, 433–438.
[CrossRef]
18. Soares, D.; Sinawe, H.; Folbe, A.J.; Yoo, G.; Badr, S.; Rowley, J.A.; Lin, H.S. Lateral oropharyngeal wall and
supraglottic airway collapse associated with failure in sleep apnea surgery. Laryngoscope 2012, 122, 473–479.
[CrossRef]
19. Green, K.K.; Kent, D.T.; D’Agostino, M.A.; Hoff, P.T.; Lin, H.S.; Soose, R.J.; Gillespie, M.B.; Yaremchuk, K.L.;
Carrasco-Llatas, M.; Woodson, B.T.; et al. Drug-Induced Sleep Endoscopy and Surgical Outcomes: A
Multicenter Cohort Study. Laryngoscope 2019, 129, 761–770. [CrossRef]
20. Lloyd, S.R.; Cartwright, R.D. Physiologic basis of therapy for sleep apnea. Am. Rev. Respir. Dis. 1987, 136,
525–526. [CrossRef]
21. Victores, A.J.; Hamblin, J.; Gilbert, J.; Switzer, C.; Takashima, M. Usefulness of sleep endoscopy in predicting
positional obstructive sleep apnea. Otolaryngol. Head Neck Surg. 2014, 150, 487–493. [CrossRef] [PubMed]
22. Safiruddin, F.; Koutsourelakis, I.; De Vries, N. Analysis of the influence of head rotation during drug-induced
sleep endoscopy in obstructive sleep apnea. Laryngoscope 2014, 124, 2195–2199. [CrossRef] [PubMed]
23. Vonk, P.E.; van de Beek, M.J.; Ravesloot, M.J.L.; de Vries, N. Drug-induced sleep endoscopy: New insights in
lateral head rotation compared to lateral head and trunk rotation in (non)positional obstructive sleep apnea
patients. Laryngoscope 2018. [CrossRef] [PubMed]
24. Johal, A.; Hector, M.P.; Battagel, J.M.; Kotecha, B.T. Impact of sleep nasendoscopy on the outcome of
mandibular advancement splint therapy in subjects with sleep-related breathing disorders. J. Laryngol. Otol.
2007, 121, 668–675. [CrossRef] [PubMed]
25. Vroegop, A.V.; Vanderveken, O.M.; Dieltjens, M.; Wouters, K.; Saldien, V.; Braem, M.J.; Van De Heyning, P.H.
Sleep endoscopy with simulation bite for prediction of oral appliance treatment outcome. J. Sleep Res. 2013,
22, 348–355. [CrossRef] [PubMed]
26. Certal, V.F.; Pratas, R.; Guimaraes, L.; Lugo, R.; Tsou, Y.; Camacho, M.; Capasso, R. Awake examination
versus DISE for surgical decision making in patients with OSA: A systematic review. Laryngoscope 2016, 126,
768–774. [CrossRef] [PubMed]
27. Blumen, M.; Bequignon, E.; Chabolle, F. Drug-induced sleep endoscopy: A new gold standard for evaluating
OSAS? Part II: Results. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2017, 134, 109–115. [CrossRef] [PubMed]
28. Pang, K.P.; Baptista, P.M.; Olszewska, E.; Braverman, I.; Carrasco-Llatas, M.; Kishore, S.; Chandra, S.;
Yang, H.C.; Wang, C.M.Z.; Chan, Y.H.; et al. Does drug-induced sleep endoscopy affect surgical outcome? A
multicenter study of 326 obstructive sleep apnea patients. Laryngoscope 2019. [CrossRef]
29. Eichler, C.; Sommer, J.U.; Stuck, B.A.; Hörmann, K.; Maurer, J.T. Does drug-induced sleep endoscopy change
the treatment concept of patients with snoring and obstructive sleep apnea? Sleep Breath. 2013, 17, 63–68.
[CrossRef]
30. Aktas, O.; Erdur, O.; Cirik, A.A.; Kayhan, F.T. The role of drug-induced sleep endoscopy in surgical planning
for obstructive sleep apnea syndrome. Eur. Arch. Otorhinolaryngol. 2015, 272, 2039–2043. [CrossRef]
31. Gobbi, R.; Baiardi, S.; Mondini, S.; Cerritelli, L.; Piccin, O.; Scaramuzzino, G. Technique and Preliminary
Analysis of Drug-Induced Sleep Endoscopy with Online Polygraphic Cardiorespiratory Monitoring in
Patients with Obstructive Sleep Apnea Syndrome. JAMA Otolaryngol. Head Neck Surg. 2017, 143, 459–465.
[CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
